GlassScriptPhysician profile
Angela Jane Mcbride
NPI 1043848195
$3,022.97
in general payments reported to CMS, 2019-2025
33 companies · $719 in 2025
The $719 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $230 · 2023: $535 · 2024: $1,540 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018 · Travel and Lodging: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.90 |
| Travel and Lodging | $775.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,340.57 | 2023-2025 | Urolift |
| Coloplast Corp | $283.79 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $156.11 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $112.89 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $103.95 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.28 | 2022 | |
| Progenics Pharmaceuticals, INC. | $76.29 | 2023-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $66.50 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $64.70 | 2023-2024 | Lithovue, Rezum Generator |
| Tolmar, INC. | $62.98 | 2023-2025 | Jatenzo, Eligard |
| Abbvie INC. | $62.65 | 2023-2024 | |
| Pfizer INC. | $53.25 | 2022-2023 | |
| Zoll Respicardia, INC. | $46.49 | 2023-2024 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.33 | 2022 | |
| Abc Home Medical Supply, INC. | $41.59 | 2024-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $38.40 | 2022 | |
| Procept Biorobotics Corporation | $30.54 | 2023 | Aquabeam Robotic System |
| Esperion Therapeutics, INC. | $30.39 | 2022 | |
| Alnylam Pharmaceuticals INC. | $29.47 | 2023 | Givlaari |
| Daiichi Sankyo INC. | $28.76 | 2025 | Enhertu |
| Medtronic, INC. | $26.43 | 2023 | Signia |
| Cvrx, INC. | $25.26 | 2025 | Barostim Neo System |
| Blue Earth Diagnostics | $24.12 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $24.09 | 2022 | |
| 180 Medical, INC. | $23.59 | 2023 | Gentlecath Glide |
| Axonics, INC. | $23.10 | 2023 | Bulkamid, Axonics |
| Halozyme INC | $21.24 | 2023 | |
| Janssen Biotech, INC. | $20.24 | 2024 | Erleada |
| Laborie Medical Technologies Corp. | $19.01 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $18.68 | 2023 | |
| Astellas Pharma US INC | $17.53 | 2023 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $15.12 | 2023 | Prolaris |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.